aspirin has been researched along with Glomerulonephritis, IGA in 5 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
Glomerulonephritis, IGA: A chronic form of glomerulonephritis characterized by deposits of predominantly IMMUNOGLOBULIN A in the mesangial area (GLOMERULAR MESANGIUM). Deposits of COMPLEMENT C3 and IMMUNOGLOBULIN G are also often found. Clinical features may progress from asymptomatic HEMATURIA to END-STAGE KIDNEY DISEASE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We herein report 3 cases of progressive IgA nephropathy and their successful treatment with a combination of aspirin and eicosapentaenoic acid (EPA) without the use of steroids." | 1.42 | Aspirin and Eicosapentaenoic Acid May Arrest Progressive IgA Nephropathy: A Potential Alternative to Immunosuppression. ( Arita, M; Hanafusa, N; Hayashi, M; Hirahashi, J; Hishikawa, K; Nangaku, M; Wada, T, 2015) |
| "Co-occurrence of BD and IgA nephropathy has only been reported in only few cases." | 1.38 | Behcet's disease and IgA nephropathy. ( Altay, M; Ceri, M; Duranay, M; Secilmis, S; Unverdi, S, 2012) |
| "Thirty-three cases of idiopathic IgA nephropathy were followed up for an average of 90." | 1.28 | IgA nephropathy: a long-term progressive study. ( Górski, A; Lao, M; Małdyk, M; Morzycka-Michalik, M; Orłowski, T; Rancewicz, Z; Smogorzewski, M; Szczesny-Nowicka, B, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirahashi, J | 1 |
| Hanafusa, N | 1 |
| Wada, T | 1 |
| Arita, M | 1 |
| Hishikawa, K | 1 |
| Hayashi, M | 1 |
| Nangaku, M | 1 |
| Altay, M | 1 |
| Secilmis, S | 1 |
| Unverdi, S | 1 |
| Ceri, M | 1 |
| Duranay, M | 1 |
| Wong, F | 1 |
| Orłowski, T | 1 |
| Górski, A | 1 |
| Rancewicz, Z | 1 |
| Morzycka-Michalik, M | 1 |
| Smogorzewski, M | 1 |
| Małdyk, M | 1 |
| Lao, M | 1 |
| Szczesny-Nowicka, B | 1 |
| Chan, MK | 1 |
| Kwan, SY | 1 |
| Chan, KW | 1 |
| Yeung, CK | 1 |
1 review available for aspirin and Glomerulonephritis, IGA
| Article | Year |
|---|---|
Liver and kidney diseases.
Topics: Acetaminophen; Anemia, Sickle Cell; Animals; Aspirin; Cholestasis; Cysts; Glomerulonephritis, IGA; G | 2002 |
1 trial available for aspirin and Glomerulonephritis, IGA
| Article | Year |
|---|---|
Controlled trial of antiplatelet agents in mesangial IgA glomerulonephritis.
Topics: Adult; Aspirin; Blood Platelets; Clinical Trials as Topic; Creatinine; Delayed-Action Preparations; | 1987 |
3 other studies available for aspirin and Glomerulonephritis, IGA
| Article | Year |
|---|---|
Aspirin and Eicosapentaenoic Acid May Arrest Progressive IgA Nephropathy: A Potential Alternative to Immunosuppression.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Drug Therapy, Combination; Eicosapentaenoic Acid; | 2015 |
Behcet's disease and IgA nephropathy.
Topics: Aspirin; Behcet Syndrome; Colchicine; Creatinine; Drug Therapy, Combination; Glomerulonephritis, IGA | 2012 |
IgA nephropathy: a long-term progressive study.
Topics: Adolescent; Adult; Aspirin; Child; Creatinine; Dipyridamole; Female; Glomerulonephritis, IGA; Humans | 1990 |